ClinicalTrials.Veeva

Menu

Duloxetine for Acute Post-mastectomy Pain

A

Assiut University

Status

Completed

Conditions

Acute Pain

Treatments

Drug: Duloxetine

Study type

Interventional

Funder types

Other

Identifiers

NCT03468348
SECI-IRB-IORG0006563-437

Details and patient eligibility

About

The objective of this study is to evaluate the analgesic effect of oral dulexitine tablet (administered 2 h before surgery) as well as the ideal dose for acute postmastectomy pain.

Full description

patients undergoing mastectomy with axillary evacuation will be divided to four groups, Placebo group: received placebo capsule Duloxetine 30: received duloxetine 30 mg capsule Duloxetine 60: received duloxetine 60 mg capsule Duloxetine 90: received duloxetine 90 mg capsule the study medication is administered orall 2 h before surgery. Primary outcome variable: the first postoperative 24 h morphine consumption Secondary outcome: the VAS pain score measured every 4 h in the first 24 h postoperatively.

Enrollment

88 patients

Sex

Female

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult females scheduled for unilateral MRM with axillary evacuation for breast cancer,
  • American Society of Anesthesiologists physical status (ASA) class I and II

Exclusion criteria

  • Patients with a known allergy to Duloxetine or morphine,
  • A history of drug or alcohol abuse,
  • Patients with impaired kidney or liver functions,
  • Patients with chronic pain or regularly receiving analgesics,
  • Any psychiatric illness that would interfere with the perception and the assessment of pain.
  • Any reason that resulted in the protocol violation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

88 participants in 4 patient groups, including a placebo group

placebo group
Placebo Comparator group
Treatment:
Drug: Duloxetine
duloxetine 30
Active Comparator group
Treatment:
Drug: Duloxetine
duloxetine 60
Active Comparator group
Treatment:
Drug: Duloxetine
duloxetine 90
Active Comparator group
Treatment:
Drug: Duloxetine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems